RxSight, Inc. Announces Board Changes
Ticker: RXST · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1111485
| Field | Detail |
|---|---|
| Company | Rxsight, Inc. (RXST) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, governance
TL;DR
RxSight's board sees a departure and two new additions, effective July 31, 2025.
AI Summary
On July 31, 2025, RxSight, Inc. reported the departure of Director David E. Johnson. The company also announced the election of two new directors, Dr. Arshad Khan and Mr. David R. Johnson, to its Board, effective immediately. These changes are part of the company's ongoing governance and strategic adjustments.
Why It Matters
Changes in board composition can signal shifts in company strategy, governance, or investor relations, potentially impacting future performance and direction.
Risk Assessment
Risk Level: low — The filing reports routine board member changes and appointments, which typically carry low immediate risk.
Key Players & Entities
- RxSight, Inc. (company) — Registrant
- David E. Johnson (person) — Departing Director
- Dr. Arshad Khan (person) — Newly Elected Director
- Mr. David R. Johnson (person) — Newly Elected Director
- July 31, 2025 (date) — Effective date of changes
FAQ
Who has departed from the RxSight, Inc. Board of Directors?
David E. Johnson has departed from the RxSight, Inc. Board of Directors as of July 31, 2025.
Who are the new directors elected to RxSight, Inc.'s Board?
Dr. Arshad Khan and Mr. David R. Johnson were elected as new directors to RxSight, Inc.'s Board.
When were the board changes effective?
The changes to the Board of Directors for RxSight, Inc. were effective July 31, 2025.
What is RxSight, Inc.'s principal executive office address?
RxSight, Inc.'s principal executive office is located at 100 Columbia, Aliso Viejo, California, 92656.
What is the Commission File Number for RxSight, Inc.?
The Commission File Number for RxSight, Inc. is 001-40690.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 by David E. Johnson regarding RxSight, Inc. (RXST).